Brind.

Jim O'Neill was nominated to advise HHS on operations and questioned regarding drug pricing deals after succeeding as deputy secretary.

1 report, 1 independent Updated Sep 16
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Jim O'Neill was nominated to advise HHS on operations and questioned regarding drug pricing deals after succeeding as deputy secretary.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped